K
Kelley A. Hutcheson
Researcher at Duke University
Publications - 20
Citations - 2976
Kelley A. Hutcheson is an academic researcher from Duke University. The author has contributed to research in topics: Myocyte & Skeletal muscle. The author has an hindex of 12, co-authored 18 publications receiving 2899 citations. Previous affiliations of Kelley A. Hutcheson include University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation
Doris A. Taylor,Atkins Bz,P Hungspreugs,T R Jones,Mary C. Reedy,Kelley A. Hutcheson,Donald D. Glower,William E. Kraus +7 more
TL;DR: In rabbits in which myoblasts were incorporated, myocardial performance was improved and the ability to regeneratefunctioning muscle after autologous myoblast transplantation could have a important effect on patients after acuteMyocardial infarction.
Journal ArticleDOI
Reducing hospital morbidity and mortality following esophagectomy
B. Zane Atkins,Ashish S. Shah,Kelley A. Hutcheson,Jennifer H. Mangum,Theodore N. Pappas,David H. Harpole,Thomas A. D'Amico +6 more
TL;DR: Morbidity and mortality of EG are significant, but most complications, including anastomotic leak, are not independent predictors of mortality.
Journal ArticleDOI
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.
Hai Wu,Beverly A. Rothermel,Shane B. Kanatous,Paul B. Rosenberg,Francisco J. Naya,John M. Shelton,Kelley A. Hutcheson,J. Michael DiMaio,Eric N. Olson,Rhonda S Bassel-Duby,R. Sanders Williams +10 more
TL;DR: A molecular pathway in which calcineurin and MEF2 participate in the adaptive mechanisms by which skeletal myofibers acquire specialized contractile and metabolic properties as a function of changing patterns of muscle contraction is delineated.
Journal ArticleDOI
Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts.
TL;DR: Comparing indices of regional contractile (systolic) and diastolic myocardial performance following transplantation of either autologous skeletal myoblasts or dermal fibroblasts into chronically injured rabbit heart suggests that both contractile and noncontractile cells can improve regional material properties or structural integrity of terminally injured heart.
Journal ArticleDOI
Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium.
B. Zane Atkins,Matthew T. Hueman,Jennifer M. Meuchel,Maisha J. Cottman,Kelley A. Hutcheson,Doris A. Taylor +5 more
TL;DR: Cellular cardiomyoplasty, a potential therapeutic option for ischemic heart disease, appears to reverse diastolic creep and thus may represent a clinical alternative to transplantation in the near future.